Cargando…
Expanding the frontiers of existing antiviral drugs: Possible effects of HIV-1 protease inhibitors against SARS and avian influenza
When unexpected diseases such as the severe acute respiratory syndrome (SARS) and avian influenza become a serious threat to public health, an immediate response is imperative. This should take into consideration existing licensed antiviral drugs against other viral diseases already known to be safe...
Autor principal: | Savarino, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108403/ https://www.ncbi.nlm.nih.gov/pubmed/15893956 http://dx.doi.org/10.1016/j.jcv.2005.03.005 |
Ejemplares similares
-
Novel antiviral activity of neuraminidase inhibitors against an avian influenza a virus
por: Ushirogawa, Hiroshi, et al.
Publicado: (2011) -
The spreading frontiers of avian-human influenza described by the free boundary
por: Lei, ChengXia, et al.
Publicado: (2013) -
Expanding the frontiers of therapy
por: Smolen, Josef S
Publicado: (2006) -
The Antiviral Potential of Host Protease Inhibitors
por: Steinmetzer, Torsten, et al.
Publicado: (2018) -
Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
por: Mahdi, Mohamed, et al.
Publicado: (2020)